Glenn Pierce

Glenn Pierce, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Global Blood Therapeutics, Inc. and Voyager Therapeutics, Inc. In total, 8 filings cover trades dated from 12 September 2018 to 5 October 2022.

On the open market, the record shows 1 purchase worth €79k and 1 sale worth €64k. The net balance comes to €16k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 4 option exercises. 2022 to date brings no purchases and 1 sale.

The record was last updated on 6 October 2022 with a transaction in Global Blood Therapeutics, Inc. The last purchase on record was published on 12 September 2018, which is 2,961 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.